Cong Liang

机构：Sun Yat-sen University, Nanfang Hospital, The First Affiliated Hospital, Sun Yat-sen University, Southern Medical University · ORCID：0000-0002-5572-5354

发表论文 42 篇 · 总被引 1493 次 · h-index 16

代表论文

• METTL3 Inhibits Antitumor Immunity by Targeting m6A-BHLHE41-CXCL1/CXCR2 Axis to Promote Colorectal Cancer (2022 · Gastroenterology · 被引 300)
• Targeting m 6 A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer (2023 · Gut · 被引 288)
• METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy (2023 · Cell Reports Medicine · 被引 154)
• Intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis through the gut–liver axis (2025 · Nature Metabolism · 被引 36)
• Long-term outcome of children with acute promyelocytic leukemia: a randomized study of oral versus intravenous arsenic by SCCLG-APL group (2023 · Blood Cancer Journal · 被引 18)
• Hepatic TM6SF2 activates antitumour immunity to suppress metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma and boosts immunotherapy (2024 · Gut · 被引 17)